BIOX Income Statement (2016-2025) | BIOX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2016	Jun2017	Jun2018	Jun2019	Jun2020	Jun2021	Dec2021	Jun2022	Jun2023	Jun2024	Jun2025
Revenue & cost
Revenue (Quarter)						0.12M		10.57M
Cost of Revenue (Quarter)	26.82M					4.83M		5.27M
Gross Profit (Quarter)	9.92M					7.77M		5.31M
Operating items
Research & Development (Quarter)	0.56M					2.84M		2.97M
Selling, General & Administrative (Quarter)	6.94M					7.29M		10.55M
Operating Expenses (Quarter)	7.49M					10.12M		13.52M
Operating Income (Quarter)	2.27M					-2.36M		-8.21M
EBIT (Quarter)	2.27M					-2.36M		-8.21M
Non-operating items
Other Non Operating Income (Quarter)						-0.14M		-0.03M
Non Operating Income (Quarter)	-4.01M					-0.14M		-0.03M
Net income details
EBT (Quarter)	-1.75M					-3.03M		-8.80M
Tax Provisions (Quarter)	1.84M					0.00M		-0.24M
Profit After Tax (Quarter)	-3.58M					-3.04M		-8.56M
Equity Income (Quarter)	-0.16M
Income from Continuing Operations (Quarter)	-3.58M					-3.04M		-8.56M
Consolidated Net Income (Quarter)	-3.58M					-3.04M		-8.56M
Income towards Parent Company (Quarter)	-3.58M					-3.04M		-8.56M
Net Income towards Common Stockholders (Quarter)	-3.58M					-3.04M		-8.56M
Additional items
EPS (Basic) (Quarter)	-0.13					-0.02		-0.05
EPS (Weighted Average and Diluted) (Quarter)						-0.02		-0.05
Shares Outstanding (Weighted Average) (Quarter)	28.10M	1.41M	28.10M	30.48M	36.12M	39.22M	0.18M	42.30M	62.15M	62.84M	63.23M
Shares Outstanding (Diluted Average) (Quarter)			28.10M	30.48M	36.42M	172.23M		182.37M
EBITDA (Quarter)	2.27M					-2.36M		-8.21M
Interest Expenses (Quarter)						0.20M		0.56M
Tax Rate (Quarter)	-105.18%					-0.10%		2.68%